https://orcid.org/0000-0003-2398-1254
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amani Lusekelo. (2023) Portrayal of the COVID-19 pandemic in political cartoons in Tanzania. Cogent Arts & Humanities 10:1.
Read now
Read now
Fei Peng, Si Lei, Quan Zhang, Yanjun Zhong & Shangjie Wu. (2022) Triglyceride/High-Density Lipoprotein Cholesterol Ratio is Associated with the Mortality of COVID-19: A Retrospective Study in China. International Journal of General Medicine 15, pages 985-996.
Read now
Read now
Alessio Nocentini, Clemente Capasso & Claudiu T. Supuran. (2022) Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?. Expert Opinion on Drug Discovery 17:6, pages 547-557.
Read now
Read now
Claudiu T. Supuran. (2021) Coronaviruses. Expert Opinion on Therapeutic Patents 31:4, pages 291-294.
Read now
Read now
Beyza Dönmüş, Sinan Ünal, Fatma Ceren Kirmizitaş & Nelisa Türkoğlu Laçin. (2021) Virus-associated ribozymes and nano carriers against COVID-19. Artificial Cells, Nanomedicine, and Biotechnology 49:1, pages 204-218.
Read now
Read now
Articles from other publishers (33)
Francesca Picarazzi & Mattia Mori. 2024. Metalloenzymes. Metalloenzymes
9
22
.
Shavkat I. Salikhov, Ibrokhim Y. Abdurakhmonov, Yuliya I. Oshchepkova, Jamolitdin F. Ziyavitdinov, Nodir Sh. Berdiev, Haji Akber Aisa, Jingshan Shen, Yechun Xu, H. Eric Xu, Xiangrui Jiang, Leike Zhang, Natalia L. Vypova, Dilshod Sh. Allaberganov, Nigora A. Tagayalieva, Erkin I. Musabaev, Gulnara A. Ibadova, Ilxom B. Rajabov & Lyubov M. Lokteva. (2023) Repurposing of Rutan showed effective treatment for COVID-19 disease. Frontiers in Medicine 10.
Crossref
Crossref
Ripul Mehrotra, Satyendra N. Shukla & Pratiksha Gaur. (2023) Metallo-antiviral aspirants: Answer to the upcoming virus outbreak. European Journal of Medicinal Chemistry Reports 8, pages 100104.
Crossref
Crossref
Natasha Naval Aggarwal, S.M. Sindhoor, N. Raghavendra Naveen, Buduru Gowthami & Prajitha Biju. (2023) Drug Reprofiling: A Prospective Approach to Battle Chronic Ailments. Journal of Health and Allied Sciences NU.
Crossref
Crossref
Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza & Hermógenes D de Oliveira. (2023)
Plant protease inhibitors against SARS-CoV-2 main protease: an
in silico
approach
. Future Virology 18:7, pages 439-454.
Crossref
Crossref
Mohamed O. Radwan, Tsugumasa Toma, Yuiichi Arakaki, Masahiro Kamo, Naoya Inoue, Ryoko Koga, Masami Otsuka, Hiroshi Tateishi & Mikako Fujita. (2023) New insight into the bioactivity of substituted benzimidazole derivatives: Repurposing from anti-HIV activity to cell migration inhibition targeting hnRNP M. Bioorganic & Medicinal Chemistry 86, pages 117294.
Crossref
Crossref
Krystyna Dobrowolska, Dorota Zarębska-Michaluk, Michał Brzdęk, Piotr Rzymski, Magdalena Rogalska, Anna Moniuszko-Malinowska, Dorota Kozielewicz, Marcin Hawro, Marta Rorat, Katarzyna Sikorska, Jerzy Jaroszewicz, Justyna Kowalska & Robert Flisiak. (2023) Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings. Journal of Clinical Medicine 12:6, pages 2371.
Crossref
Crossref
Vijaya Majumdar, N. K. Manjunath, Raghuram Nagarathna, Suryanarayan Panigrahi, Muralidhar Kanchi, Sarthak Sahoo, Hongasandra R. Nagendra, Adithi Giridharan, Mounika Reddy & Rakshitha Nayak. (2023) Adjunct tele-yoga on clinical status at 14 days in hospitalized patients with mild and moderate COVID-19: A randomized control trial. Frontiers in Public Health 11.
Crossref
Crossref
Ajay Manaithiya, Ozair Alam, Shruti Mittal, Mohd. Javed Naim, Mohd. Imran, Ahmed Subeh Alshrari, Aadil A. Sheikh & Imran A. Khan. (2023) An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV
and SARS-CoV-2 3CLpro. Mini-Reviews in Medicinal Chemistry 23:5, pages 576-632.
Crossref
Crossref
Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren, Adna Smajkan, Amina Karić, Husein Djedović & Jasmin Šutković. (2022) A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Crossref
Yizhou Jiang, Limor Rubin, Zhiwei Zhou, Haibo Zhang, Qiaozhu Su, Sheng-Tao Hou, Philip Lazarovici & Wenhua Zheng. (2022) Pharmacological therapies and drug development targeting SARS-CoV-2 infection. Cytokine & Growth Factor Reviews 68, pages 13-24.
Crossref
Crossref
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Marquez, Kawthar Mohamed, Lamin Ndow, Dorota Zarębska-Michaluk, Nima Rezaei & Piotr Rzymski. (2022) Oral antiviral treatments for COVID-19: opportunities and challenges. Pharmacological Reports 74:6, pages 1255-1278.
Crossref
Crossref
Francesca Picarazzi, Marika Zuanon, Gaia Pasqualetto, Silvia Cammarone, Isabella Romeo, Mark T. Young, Andrea Brancale, Marcella Bassetto & Mattia Mori. (2022) Identification of Small Molecular Chaperones Binding P23H Mutant Opsin through an In Silico Structure-Based Approach. Journal of Chemical Information and Modeling 62:22, pages 5794-5805.
Crossref
Crossref
Nikhat Farhana, Mohammed Gulzar Ahmed, Mohammed Asif Iqbal, Nishmitha Gretta D’Souza, Sudhina Makuttan, Natasha Naval Aggarwal & Abdul Rahamanulla. 2022. Antiviral Drugs - Intervention Strategies. Antiviral Drugs - Intervention Strategies.
Muhammad Nawaz, Muhammad Adnan Ashraf, Muhammad Asad Ali, Muhammad Zubair Shabbir, Muhammad Abu Bakr Shabbir, Imran Altaf, Sohail Raza, Saira Rafique, Sohail Hassan, Nageen Sardar, Adnan Mehmood, Muhammad Waqar Aziz, Sehar Fazal, Muhammad Tahir Khan, Hafiz Muhammad Moavia Atique, Ali Asif, Zia Ullah, Mubashir Iqbal, Talha Imtiaz, Muhammad Anwar, Nadia Mukhtar & Tahir Yaqub. (2022) Renessans Helps in Early Clearance of SARS-CoV-2: In-Vivo Activity of the Iodine Complex in Rhesus macaque. Life 12:9, pages 1424.
Crossref
Crossref
Tianshi Wang, Ying Cao, Haiyan Zhang, Zihao Wang, Cheuk Him Man, Yunfan Yang, Lingchao Chen, Shuangnian Xu, Xiaojing Yan, Quan Zheng & Yi‐Ping Wang. (2022) COVID‐19 metabolism: Mechanisms and therapeutic targets. MedComm 3:3.
Crossref
Crossref
Robert Flisiak, Dorota Zarębska-Michaluk, Marta Flisiak-Jackiewicz & Piotr Rzymski. (2022) Updates in Management of SARS-CoV-2 Infection. Journal of Clinical Medicine 11:15, pages 4472.
Crossref
Crossref
Ahmad Reza Farmani, Forough Mahdavinezhad, Carolina Scagnolari, Mahsa Kouhestani, Sadegh Mohammadi, Jafar Ai, Mohammad Hasan Shoormeij & Nima Rezaei. (2021) An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Delivery and Translational Research 12:7, pages 1605-1615.
Crossref
Crossref
Mohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill, Leah Ellis, Manya Mirchandani, Alireza Davoudi, Gohar Eslami, Fatemeh Roozbeh, Farhang Babamahmoodi, Nima Rouhani, Ahmad Alikhani, Narges Najafi, Roya Ghasemian, Hossein Mehravaran, Azin Hajialibeig, Mohammad Reza Navaeifar, Leila Shahbaznejad, Golnar Rahimzadeh, Majid Saeedi, Reza Alizadeh-Navai, Mahmood Moosazadeh, Shahab Saeedi, Seyedeh-Kiana Razavi-Amoli, Shaghayegh Rezai, Fereshteh Rostami-Maskopaee, Fatemeh Hosseinzadeh, Faezeh Sadat Movahedi, John S. Markowitz & Reza Valadan. (2022) Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials. Frontiers in Medicine 9.
Crossref
Crossref
Gianni Testino, Teo Vignoli, Valentino Patussi, Pierluigi Allosio, Maria Francesca Amendola, Sarino Aricò, Aniello Baselice, Patrizia Balbinot, Vito Campanile, Tiziana Fanucchi, Giovanni Greco, Livia Macciò, Cristina Meneguzzi, Davide Mioni, Vincenzo Ostilio Palmieri, Michele Parisi, Doda Renzetti, Raffaella Rossin, Claudia Gandin, Luigi Carlo Bottaro, Mauro Bernardi, Giovanni Addolorato, Lisa Lungaro, Giorgio Zoli, Emanuele Scafato & Fabio Caputo. (2021) Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Digestive Diseases and Sciences 67:6, pages 1975-1986.
Crossref
Crossref
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros & Celso Cunha. (2022) Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates. Molecules 27:9, pages 2723.
Crossref
Crossref
Wallace K. B. Chan, Keith M. Olson, Jesse W. Wotring, Jonathan Z. Sexton, Heather A. Carlson & John R. Traynor. (2022) In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. Scientific Reports 12:1.
Crossref
Crossref
Bruce Bloom. 2022. Drug Repurposing. Drug Repurposing
74
100
.
Francesco Caruso, Jens Z. Pedersen, Sandra Incerpi, Sarjit Kaur, Stuart Belli, Radu-Mihai Florea & Miriam Rossi. (2022) Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment. International Journal of Molecular Sciences 23:3, pages 1849.
Crossref
Crossref
Kamlesh Kumari, Ajay Kumar, Prashant Singh & Nagendra Kumar Kaushik. (2022) In silico study of remdesivir with and without ionic liquids having different cations using DFT calculations and molecular docking. Journal of the Indian Chemical Society 99:2, pages 100328.
Crossref
Crossref
Gianni Testino, Teo Vignoli, Valentino Patussi, Pierluigi Allosio, Maria Francesca Amendola, Sarino Aricò, Aniello Baselice, Patrizia Balbinot, Vito Campanile, Tiziana Fanucchi, Livia Macciò, Cristina Meneguzzi, Davide Mioni, Michele Parisi, Doda Renzetti, Raffaella Rossin, Claudia Gandin, Luigi Carlo Bottaro, Giacomo Caio, Lisa Lungaro, Giorgio Zoli, Emanuele Scafato & Fabio Caputo. (2021) Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA). Addiction Biology 27:1.
Crossref
Crossref
Arpan Acharya, Kabita Pandey, Michellie Thurman, Elizabeth Klug, Jay Trivedi, Kalicharan Sharma, Christian L. Lorson, Kamal Singh & Siddappa N. Byrareddy. (2021) Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants. Journal of Virology 95:24.
Crossref
Crossref
Chirag N. Patel, Siddhi P. Jani, Dharmesh G. Jaiswal, Sivakumar Prasanth Kumar, Naman Mangukia, Robin M. Parmar, Rakesh M. Rawal & Himanshu A. Pandya. (2021) Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations. Scientific Reports 11:1.
Crossref
Crossref
Sharna-kay Daley & Geoffrey A. Cordell. (2021) Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs. Molecules 26:13, pages 3800.
Crossref
Crossref
Aliye Gediz Erturk, Arzu Sahin, Ebru Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, Melek Gul, Seda Mesci, Serpil Eryilmaz, Sirin Oba Ilter & Tuba Yildirim. (2021) A Multidisciplinary Approach to Coronavirus Disease (COVID-19). Molecules 26:12, pages 3526.
Crossref
Crossref
Piotr Rzymski, Leszek Borkowski, Marcin Drąg, Robert Flisiak, Jacek Jemielity, Jacek Krajewski, Agnieszka Mastalerz-Migas, Andrzej Matyja, Krzysztof Pyrć, Krzysztof Simon, Michał Sutkowski, Jacek Wysocki, Joanna Zajkowska & Andrzej Fal. (2021) The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation. Vaccines 9:2, pages 109.
Crossref
Crossref
Elizabeth A. Lopes, Maria M. M. Santos & Mattia Mori. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
219
240
.
Ana-Belén Blázquez & Juan-Carlos Saiz. (2020) Potential for Protein Kinase Pharmacological Regulation in Flaviviridae Infections. International Journal of Molecular Sciences 21:24, pages 9524.
Crossref
Crossref